The illustrious S&P/ASX 200 Index (ASX: XJO) is home to a good number of shares with true blue chip status. So many, in fact, it can be hard to decide which ones to include in your portfolio.
In order to narrow things down, I have picked out two blue chip ASX 200 shares which are highly rated right now. They are as follows:
The first ASX 200 blue chip share to look at is CSL. It is one of the world’s leading biotechnology companies, responsible for the CSL Behring and Seqirus businesses.
Last week the company released its half year results and revealed a 16.9% increase in revenue to US$5,739 million and a massive 45% jump in net profit after tax to US$1,810 million. This was driven by a surge in flu vaccine sales, the…